A detailed history of Eventide Asset Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 718,814 shares of TGTX stock, worth $23.1 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
718,814
Previous 718,814 -0.0%
Holding current value
$23.1 Million
Previous $12.8 Million 31.49%
% of portfolio
0.3%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.02 - $21.3 $3.64 Million - $5.95 Million
279,340 Added 63.56%
718,814 $10.9 Million
Q4 2023

Feb 14, 2024

BUY
$6.68 - $18.81 $2.94 Million - $8.27 Million
439,474 New
439,474 $7.51 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.67B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Eventide Asset Management, LLC Portfolio

Follow Eventide Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eventide Asset Management, LLC with notifications on news.